Pierre Marquet

Pierre Marquet is a Professor of Medical Pharmacology at the University of Limoges, serving as Director of U1248 Inserm/University of Limoges and Head of the Department of Pharmacology, Toxicology, and Pharmacovigilance at CHU Limoges. With over 350 publications indexed in the Science Citation Index and an H-index of 54 (Web of Science), he has established himself as a leading authority in immunosuppressant pharmacology and precision medicine for organ transplantation.

His academic journey began with a Doctorate in Medicine from the University of Limoges (1986), followed by a PhD in Life and Health Sciences from University Paris V (1992), and a Habilitation to Supervise Research from the University of Limoges (1998). He progressed from Associate Professor (1998-2001) to Full Professor (since 2001), while directing research units from EA 1313 (2000-2007) to U1248 (since 2007).

Marquet's research focuses on immunosuppressant pharmacology, pharmacometrics, and pharmacoepidemiology, with particular emphasis on developing precision medicine tools for transplantation. His groundbreaking work includes developing the Immunosuppressants Bayesian Adaptation Expert System (IBSA), clinically validating mycophenolate mofetil dose adaptation (resulting in a 60% decrease in acute kidney graft rejection episodes), and coordinating major European research programs including BIOMARGIN (FP7 HEALTH) and REXETRIS (Health Data Hub).

His publication record demonstrates consistent scholarly impact across transplantation pharmacology, with recent works focusing on immune cell composition in kidney rejection, digital holography applications, and consensus guidelines for therapeutic drug monitoring. These publications reflect his interdisciplinary approach spanning clinical pharmacology, immunology, and translational research.

• President of the European Association of Clinical Pharmacology and Therapeutics (2021-2023)
• Treasurer of the International Union of Basic and Clinical Pharmacology (since 2022)
• Scientific Site Coordinator for INSERM (since 2024)
• President of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (2011-2013)

As an educator, Marquet teaches pharmacology across multiple programs at the University of Limoges, including the Specific Health Access Pathway, Medicine programs (years 2-4), and the Master's program in Immune Interactions and Cellular Engineering (I3C). His research leadership extends to coordinating 16 clinical and pharmacoepidemiological studies since 1997, demonstrating sustained commitment to advancing evidence-based transplantation medicine.